| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |